Medications
GLP-1 medications
Each medication page collects every priced offering in our dataset — branded and compounded, injectable and oral — with the provider, plan structure, and evidence status for each row. Class-level facts only; nothing here is dosing or treatment advice.
Semaglutide
A GLP-1 receptor agonist available as FDA-approved branded products (including Wegovy) and, separately, as compounded preparations that are not FDA-approved.
32 priced rows across 14 reviewed providers · 3 related clinical studies in the casebook —see all semaglutide prices
Tirzepatide
A dual GIP/GLP-1 receptor agonist available as FDA-approved branded products (Zepbound, Mounjaro) and, separately, as compounded preparations that are not FDA-approved.
48 priced rows across 18 reviewed providers · 15 related clinical studies in the casebook —see all tirzepatide prices
Liraglutide
An older, daily-injection GLP-1 receptor agonist. Coverage in our current dataset is thin — one priced row — and the page says so rather than padding it.
1 priced row across 1 reviewed provider —see all liraglutide prices
Oral GLP-1 options
Pill-form GLP-1 medications: oral semaglutide tablets and orforglipron, a non-peptide oral GLP-1 receptor agonist. Distinct from compounded sublingual or ODT preparations, which are not FDA-approved.
3 priced rows across 1 reviewed provider · 2 related clinical studies in the casebook —see all oral glp-1 options prices
How to read these pages
Prices shown are the providers' listed figures with their evidence status — most areprovider-reported or unverified, and none currently carry our "Verified by GLP Ranked" badge (see why). Compounded preparations are not FDA-approved. Branded and compounded rows are labeled and should never be read as interchangeable products at different prices.
Cite this page
GLP Ranked. "GLP-1 medications." Updated 2026-07-24. https://glpranked.com/medications/
GLP Ranked. "GLP-1 medications." Updated 2026-07-24. https://glpranked.com/medications/